एपीए उद्धरण

Herbertz, S., Sawyer, J. S., Stauber, A. J., Gueorguieva, I., Driscoll, K. E., Estrem, S. T., . . . Lahn, M. M. (2015). Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. Drug Des Devel Ther.

शिकागो स्टाइल उद्धरण

Herbertz, Stephan, et al. "Clinical Development of Galunisertib (LY2157299 Monohydrate), a Small Molecule Inhibitor of Transforming Growth Factor-beta Signaling Pathway." Drug Des Devel Ther 2015.

एमएलए उद्धरण

Herbertz, Stephan, et al. "Clinical Development of Galunisertib (LY2157299 Monohydrate), a Small Molecule Inhibitor of Transforming Growth Factor-beta Signaling Pathway." Drug Des Devel Ther 2015.